Rocket Pharmaceuticals News and Activities
Presence
Rocket Pharmaceuticals develops gene therapies for rare genetic diseases. Its products and research programs serve patients with serious inherited conditions, healthcare providers, and treatment centers.
Rocket Pharmaceuticals products and services overview:
- Gene therapies
- Rare disease treatments
- Clinical research
- Biotechnology development
Revenue: ~$0 million
Employees: 320
Headquarters: Cranbury, United States (USA)
Rocket Pharmaceuticals is one of the...
Rocket Pharmaceuticals is a company listed under the stock ticker RCKT (US).
Executives
View the org chart displaying its 19 main executives
Most searched biographies at Rocket Pharmaceuticals
- Gaurav Shah, Chief Executive Officer and President
- Carsten Boess, Independent Director
- Elisabeth Bjoerk, Director
Popular executive movements at Rocket Pharmaceuticals
- Pedro Granadillo, Independent Director, has left the company (posted on October 6 2025).
- Madeline Innis, who was Director, People Operations and Innovation, is promoted to Senior Director, Head of People Operations, Technology and Total Rewards (posted on September 8 2025).
Create your alert
to follow the executive moves at Rocket Pharmaceuticals.
Pharmaceuticals
Rocket Pharmaceuticals has 1,913 competitors including Sanofi (France), Eli Lilly (United States (USA)) and Moderna (United States (USA)).
Popular M&A news in Pharmaceuticals
- Contraline has just announced a $93 Million fundraising (posted on June 3 2026).
- Hims & Hers has acquired Eucalyptus (posted on June 2 2026).
- Apotex has filed its IPO. Its stock ticker will be TSX. (posted on June 2 2026).
Popular contacts in Pharmaceuticals
News
Press releases by Rocket Pharmaceuticals
- Rocket Pharmaceuticals Appoints Mayo Pujols as Chief Technical Officer and Strengthens Manufacturing Capabilities | Rocket Pharmaceuticals, Inc.
- Rocket Pharmaceuticals to Present at William Blair Biotech Focus Conference | Rocket Pharmaceuticals, Inc.
- Rocket Pharmaceuticals Presents Positive Top-line Data from Severe Leukocyte Adhesion Deficiency-I Program at the 25th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT) | Rocket Pharmaceuticals, Inc.
- Rocket Pharmaceuticals Presents Positive Clinical Data from Danon Disease, Fanconi Anemia and Pyruvate Kinase Deficiency Programs at the 25th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT) | Rocket Pharmaceuticals, Inc.
- Rocket Pharmaceuticals to Present at UBS Global Healthcare Conference | Rocket Pharmaceuticals, Inc.
- Rocket Pharmaceuticals Reports First Quarter 2022 Financial Results and Highlights Recent Progress | Rocket Pharmaceuticals, Inc.
- Rocket Pharmaceuticals to Present at the Bank of America Securities 2022 Global Healthcare Conference | Rocket Pharmaceuticals, Inc.
- View more press releases Close
Social media about Rocket Pharmaceuticals
- Rocket Pharmaceuticals on Wikipedia, Google News & Yahoo Finance
- Rocket Pharmaceuticals on LinkedIn, X (Twitter) & YouTube
